Biogen Inc
XHAM:IDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
XHAM:IDP
|
US |
|
Kumba Iron Ore Ltd
F:KUI
|
ZA |
|
A
|
Austal Ltd
OTC:AUTLF
|
AU |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
DUS:MUV2
|
DE |
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
CH |
|
Equinor ASA
OSE:EQNR
|
NO |
|
H
|
Hanover Insurance Group Inc
XBER:AF4
|
US |
Wall St Price Targets
IDP Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for IDP is 196.55 EUR with a low forecast of 132.23 EUR and a high forecast of 274.93 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDP's stock price target?
Price Target
196.55
EUR
According to Wall Street analysts, the average 1-year price target for IDP is 196.55 EUR with a low forecast of 132.23 EUR and a high forecast of 274.93 EUR.
What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Biogen Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Biogen Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 27%.
What is the Net Income forecast for Biogen Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 14%.
